GlassScriptPhysician profile
Om P Ahuja
NPI 1861563058
$2,320.46
in general payments reported to CMS, 2019-2025
19 companies · $538 in 2025
The $538 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $138 · 2021: $227 · 2022: $181 · 2023: $530 · 2024: $321 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,341 · Education: $49.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,340.67 |
| Education | $49.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $752.91 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $355.42 | 2019-2025 | Nucala, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $197.84 | 2020-2022 | |
| Amgen INC. | $159.00 | 2023-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.35 | 2019-2023 | Ofev |
| Chiesi USA, INC. | $132.01 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2024 | Uptravi, Opsumit |
| Gilead Sciences, INC. | $96.26 | 2019 | |
| Viatris Specialty LLC | $58.82 | 2025 | Yupelri |
| Travere Therapeutics, INC. | $56.69 | 2024 | |
| Astellas Pharma US INC | $44.70 | 2019 | |
| Mylan Specialty L.P. | $39.19 | 2019 | |
| Csl Behring | $33.64 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $29.10 | 2019 | |
| Genzyme Corporation | $24.07 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.86 | 2019 | |
| Insmed, INC. | $16.24 | 2020 | |
| Merck Sharp & Dohme LLC | $16.21 | 2019 | |
| Medtronic Vascular, INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Om Ahuja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.